A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development

Abstract. Boerma M, Forsberg L, van Zeijl L, Morgenstern R, de Faire U, Lemne C, Erlinge D, Thulin T, Hong Y, Cotgreave IA (Karolinska Institute and Karolinska Hospital, Stockholm; Lund University, Lund, Sweden. Washington University School of Medicine, MO, USA). A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development. J Intern Med 1999; 246: 211–218.

[1]  S. Bale,et al.  Linkage studies in erythrokeratodermias: fine mapping, genetic heterogeneity and analysis of candidate genes. , 1997, The Journal of investigative dermatology.

[2]  I. Cotgreave,et al.  Differential regulation of gap junctions by proinflammatory mediators in vitro. , 1997, The Journal of clinical investigation.

[3]  M. Rook,et al.  Gap junctions in human umbilical cord endothelial cells contain multiple connexins. , 1997, The American journal of physiology.

[4]  J. Dempsey.  Sleep apnea causes daytime hypertension. , 1997, The Journal of clinical investigation.

[5]  V. Krutovskikh,et al.  Human connexin 37 is polymorphic but not mutated in tumours. , 1996, Carcinogenesis.

[6]  R. Alexander,et al.  Endothelial control of the cardiovascular system: recent advances , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  Andrew G. Dean,et al.  Epi info, version 6 : a word-processing, database, and statistics program for public health on IBM-compatible microcomputers , 1996 .

[8]  M. Fillinger,et al.  Endothelial cell modulation of smooth muscle cell morphology and organizational growth pattern , 1996, Annals of vascular surgery.

[9]  M. Bond,et al.  Ultrasound protocol and quality control procedures in the European Lacidipine Study on Atherosclerosis (ELSA). , 1996, Blood pressure. Supplement.

[10]  D. Paul,et al.  Connexins, connexons, and intercellular communication. , 1996, Annual review of biochemistry.

[11]  C. Zuppan,et al.  Mutations of the Connexin43 gap-junction gene in patients with heart malformations and defects of laterality. , 1995, The New England journal of medicine.

[12]  U. de Faire,et al.  Carotid intima-media thickness and plaque in borderline hypertension. , 1995, Stroke.

[13]  I. Budunova,et al.  Review. Alteration of gap junctional intercellular communication during carcinogenesis , 1994 .

[14]  R. Veenstra,et al.  Molecular cloning and functional expression of human connexin37, an endothelial cell gap junction protein. , 1993, The Journal of clinical investigation.

[15]  A. Moreno,et al.  Gap junctions. Multiplicity of controls in differentiated and undifferentiated cells and possible functional implications. , 1993, Advances in second messenger and phosphoprotein research.

[16]  J. Haefliger,et al.  Connexin40, a component of gap junctions in vascular endothelium, is restricted in its ability to interact with other connexins. , 1993, Molecular biology of the cell.

[17]  C. Berry,et al.  Myoendothelial contacts in arteriolosclerosis , 1992, The Journal of pathology.

[18]  H. Yamasaki.  Gap junctional communication and carcinogenesis , 1990 .

[19]  H. Yamasaki,et al.  Gap junctional intercellular communication and carcinogenesis. , 1990, Carcinogenesis.

[20]  C. Haudenschild,et al.  Gap junction messenger RNA expression by vascular wall cells. , 1990, Circulation research.

[21]  J. Trosko,et al.  Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. , 1979, Science.

[22]  D. Fitzgerald,et al.  Tumor promoters inhibit metabolic cooperation in cocultures of epidermal and 3T3 cells. , 1979, Biochemical and biophysical research communications.